Hi [[ session.user.profile.firstName ]]

Medical Research

  • Key Learning Objectives

    - Get an introduction to Six Sigma metrics
    - Learn what Six Sigma metrics are and how can they help the laboratory
    - See how laboratory tests perform on a Six Sigma scale
    - Learn about assessment tools for quality control strategy
  • A unique Q&A session/open forum panel debate.

    It is likely that you interact with ‘the cloud’ on various devices, multiple times throughout the day. However, for pharma we have only just scratched the surface regarding what the cloud can offer in terms of security, connectivity and efficacy. ‘Business analytics’ and ‘cloud’ are often misunderstood.

    To answer this, pharmaphorum, in conjunction with industry stalwarts Equinix, present a unique Q&A event, offering the opportunity to ask any questions you may have around what the cloud can do, and how to remain compliant in utilising this technology.

    This debate is an open forum and the expert panel will offer insight about interaction between the cloud and pharma with a particular focus on:
    • Patient outcomes – The cloud and patients, what are the routes to improving outcomes?
    • Internet of things – As the ways to gather data and interact increase exponentially, how does the cloud support this? What are the opportunities and can we eliminate the risk?
    • Data and security – How to achieve compliance almost automatically.
    • Collaboration – Why and how the cloud enables true partnership working.
  • The key-topics that will be discussed during this interactive webinar include:

    •The AH impact measurement approach; Exposure, engagement, conversion and effectiveness
    •Defining KPIs relevant to your brand strategy & objectives
    •Best case – Worst case
    •Creating a dashboard
    •Q&A
  • As a future ready healthcare organization, your IT is expected to generate new revenue sources and improve clinical and financial outcomes — all while managing risk and consumer expectations. It needs to be agile, modular and secure while taking proactive steps to achieve a large number of goals at once. As part of our new Future Faster initiative, Dell has partnered with International Data Corporation (IDC), a leading market research, analysis and advisory firm, to help IT and business leaders gain an understanding of the central role that healthcare IT will play in achieving the objectives of healthcare reform, by outlining approaches to meet these goals. Register now for this insightful webinar to learn from the ultimate authority in healthcare and IT. The trinity of speakers include a leading IDC analyst, a practitioner and technology evangelist from Dell and your industry peer ,. Together they will analyze the trends that will shape the future of healthcare and providing a technology roadmap to get future ready, faster.In this webinar, you’ll learn: • Why is it important to be future ready and align your business and IT priorities • What next generation solutions that you could embrace to be future ready?• How are your industry counterparts leveraging IT to be future ready? Related content: • Download this IDC Health Insight paper titled: The Future Ready Healthcare Organization: A Roadmap for Infrastructure Transformation • Download this infograph: Enable a future-ready healthcare organization with infrastructure transformation
  • Join us for a free webinar with author Karl Whittle as he talks us through his latest book Nuclear Materials Science.

    Thurs 12 May 2016
    3.00 p.m. BST / 10.00 a.m. EST

    Covering all aspects of his latest book Nuclear Materials Science, Karl Whittle expands on the research included and gives details on the videos, problems and teaching aids that make this a must read for all students in materials, engineering and physics.

    There will also be a live Q&A session at the end.
  • The rich data in your imaging archive is a resource that has largely been untapped. But now, Dell’s Clinical Cloud Services can help you tap that resource to impact population health and predict hidden risks in your patient population. Using automated machine vision medical image analysis, this new technology identifies patients at risk for chronic diseases such as osteoporosis, heart disease and other conditions, possibly well ahead of overt symptoms. Think of the value this could bring to patients and the advantage it would offer to a healthcare organization in a value-based reimbursement environment. Using existing prescribed imaging studies, Dell’s Imaging Analytics Platform selects appropriate studies that are analyzed for indications of disease presence. The platform makes the results available as reports, which are shared via HL7 or as DICOM objects. These reports are used by primary care physicians and care management program coordinators to provide follow up with patients on diagnostic tests and preventative care programs.
  • Vitamin C is an essential nutrient with many important functions in the body, such as immune-system stimulation, growth and repair of tissue, cardiovascular health, bone health and neutralizing harmful free radicals. Recent science has highlighted its potential health benefits, reaching far beyond its antioxidant function for which vitamin C is primarily known. As vitamin C is a water-soluble vitamin which the body cannot produce by itself, it must be obtained from the diet or from supplements. Yet, although vitamin C is a common constituent in most fruits and vegetables, many people are still deficient worldwide.

    Join us on May 16th, so that you can be one of the first to see our new webinar on the role of vitamin C in human health and disease. The session will be presented by Prof. Jens Lykkesfeldt, Faculty of Health & Medical Sciences at University of Copenhagen, and he will be joined by DSM’s Prof. Manfred Eggersdorfer and Jacob Bauly. Together, they will discuss the science behind vitamin C, provide examples of its key known functions, as well as share the potential health benefits of consuming it in higher doses. If you miss the first showing, don’t worry - the webinar will also be made available on demand.

    This presentation is developed for scientific information purposes only and is not intended for marketing and/or sales claims purposes.
  • Vitamin C is an essential nutrient with many important functions in the body, such as immune-system stimulation, growth and repair of tissue, cardiovascular health, bone health and neutralizing harmful free radicals. Recent science has highlighted its potential health benefits, reaching far beyond its antioxidant function for which vitamin C is primarily known. As vitamin C is a water-soluble vitamin which the body cannot produce by itself, it must be obtained from the diet or from supplements. Yet, although vitamin C is a common constituent in most fruits and vegetables, many people are still deficient worldwide.

    Join us on May 16th, so that you can be one of the first to see our new webinar on the role of vitamin C in human health and disease. The session will be presented by Prof. Jens Lykkesfeldt, Faculty of Health & Medical Sciences at University of Copenhagen, and he will be joined by DSM’s Prof. Manfred Eggersdorfer and Jacob Bauly. Together, they will discuss the science behind vitamin C, provide examples of its key known functions, as well as share the potential health benefits of consuming it in higher doses. If you miss the first showing, don’t worry - the webinar will also be made available on demand.

    This presentation is developed for scientific information purposes only and is not intended for marketing and/or sales claims purposes.
  • Demand for telehealth is on the rise in APAC as healthcare industry stakeholders across the region seek to address challenges of an ageing population and rising healthcare costs. However, market sustainability heavily depends on the establishment of successful business models that provide holistic health and wellness solutions by creating an ecosystem of products and services. In this briefing we will discuss the APAC Telehealth market opportunity with in-depth analysis of technologies, regulations, industry partnerships and business models that will help shape the future of care delivery in the region.
  • In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.

    But continued ‘evolution’ is no longer acceptable - a more revolutionary approach to customer engagement design that makes it easy for front line employees to engage andmakes it relevant and unique for the customer is needed before it is too late.

    On 19 May EY, in association with PMGroup, will host a free webinar on customer engagement design in pharma and time to move beyond the rhetoric, and I would like to invite you to register for it - either to watch it live on the day or for access to a recorded version.
  • We will take a deeper look at the automated creation and curation of Scopus Author Profiles and discuss how researchers can use Scopus to showcase their work.
  • For product designers, research scientists and engineers, a computational model that predicts the behaviour of a design is only the first step in the modelling process. Once a model has been solved the next step is to optimize the design. This might involve minimising the amount of material needed to safely support a structure, or maximising the throughput of a chemical in a chemical reactor. This optimization process can be automated using the Optimization Module in COMSOL Multiphysics®. You can pick one or more objective functions to be minimised, identify which modelling inputs can be varied to achieve the optimal design, and specify a set of constraints that a model must satisfy. In this webinar we will show you how to use the geometry optimization capabilities of COMSOL Multiphysics® version 5.2 to find the best designs quickly and easily. The presentation will feature a live modelling demo and finish with a Q&A session.
  • You wouldn’t operate a ventilator or administer an IV without knowing there are scientific studies that back up your procedures. You learned best practices supported by scientific research.

    We have the science and consensus to support UV disinfection best practices. Best practices that have resulted in infection rate reductions in real hospital environments.

    Your discussion will be led by esteemed experts Dr. William Jarvis and Dr. Thomas Kelley.

    William Jarvis, MD is a world leader in infection prevention. Among many other accomplishments he worked at the Centers for Disease Control and Prevention for 23 years, and has published over 450 peer reviewed papers. Recently it was said of Dr. Jarvis, “His decades of service and uncompromised commitment to [infection prevention] has lead to changes in how infection control is administered and has saved many lives.”

    Dr. Jarvis will discuss:
    -Most recent CDC and SHEA guidelines, and the metrics involved
    -A review of the science available on UV technologies in the market
    -What to look for when evaluating a UV technology

    Thomas Kelley, MD is Chief of Quality and Clinical Transformation at Orlando Health. He is a practicing primary care physician in Florida and has been a champion of quality improvement his entire career. He developed the first quality improvement council for the residency program when he was a faculty physician training residents at Atlanta Medical Center, and has continued to give his time and expertise to the causes of patient safety and quality care ever since. Colleagues say, “Dr. Kelley is a true champion for quality.”

    Dr. Kelley will discuss:
    -An integrated disinfection program with pulsed xenon enlightening best practices
    -Review of the results from a system-wide deployment of pulsed xenon light technology
    -How they achieved a $3.8M cost avoidance from HAI rate reduction in 12 months
  • In this briefing we will discuss the APAC Generics and Biosimilars market opportunity with in-depth analysis of emerging trends, industry partnerships and business models that will help shape the future of generic drugs market in the region.

    •Top Attractive Segments within Generics and Biosimilars
    •Key Trends and Emerging Opportunities
    •Market Game-Changers Across APAC Countries
    •Innovative business models
  • The FDA’s Office of Pharmaceutical Quality (OPQ) is working to encourage the development and adoption of emerging technologies in the pharmaceutical industry that have potential to enhance drug product quality. To achieve this goal, OPQ established the emerging technology team (ETT) program and focuses on advancing regulatory science for emerging technologies. OPQ has identified Continuous Manufacturing as one such emerging technology which has the potential to increase the efficiency, flexibility, agility, and robustness of pharmaceutical manufacturing. The ETT provides industry early engagement opportunities with FDA to receive feedback on potential technical and regulatory issues and FDA’s recommendations for regulatory submission content related to continuous manufacturing and other emerging technologies. In addition, OPQ has started a regulatory science and research program on continuous manufacturing to address remaining gaps in our knowledge and experience. Our research program is currently focused on the following areas in (1) integrated process modeling, (2) understanding of the impact of material properties, and (3) implementation of advanced process control strategies and real time release testing. The results and knowledge developed in this program can be utilized to support the implementation of continuous manufacturing and to ensure that FDA regulatory policies reflect state-of-the-art manufacturing science.
  • This webinar will focus on the metrics that Scopus offers at the article, author, and journal level
  • Skin cancer is by far the most prevalent cancer. Each year, approximately 3.4 million people in the US alone are diagnosed with some form of skin cancer. Skin cancer can be highly treatable if it is detected and classified early, and this detection and classification is often aided by immunohistochemistry. This presentation covers many of the basic science, facts, and statistics of skin cancer, as well as the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in the accurate diagnosis and survival rates of skin cancer. Continuing education credits for attending this webinar will be offered through the National Society of Histotechnology